Neuronal ICAM-5 Plays a Neuroprotective Role in Progressive Neurodegeneration
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) leading to CNS inflammation and neurodegeneration. Current anti-inflammatory drugs have only limited efficacy on progressive neurodegenerative processes underlining the need to understand immune-mediated neur...
Main Authors: | Katharina Birkner, Julia Loos, René Gollan, Falk Steffen, Beatrice Wasser, Tobias Ruck, Sven G. Meuth, Frauke Zipp, Stefan Bittner |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00205/full |
Similar Items
-
The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis
by: Katharina Birkner, et al.
Published: (2017-09-01) -
Targeting Voltage-Dependent Calcium Channels with Pregabalin Exerts a Direct Neuroprotective Effect in an Animal Model of Multiple Sclerosis
by: Petra Hundehege, et al.
Published: (2018-11-01) -
Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed Therapy
by: Jacqueline M. Orian, et al.
Published: (2021-02-01) -
Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond
by: Tobias Ruck, et al.
Published: (2015-07-01) -
Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia
by: Mei Fang, et al.
Published: (2018-11-01)